Back to the Top
There a a few bioavailability/bioequivalence guidelines I have
noticed. Which one would you use specifically for a parallel study
(guidance name and section please). The drug is a biologic with
considerable variability, so the FDA only wants a comparison, not a
show of bioequivalence. Thanks, Clerk Maxwell
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Parallel Bioequivalence Study" as the subject | Support PharmPK by using the |
Copyright 1995-2011 David W. A. Bourne (david@boomer.org)